Management ChangeJul 2, 2026, 04:38 PM
Hepion Pharmaceuticals Appoints Danina Fisher & Gary S. Stetz, II to Board
AI Summary
Hepion Pharmaceuticals, Inc. announced the appointment of Danina Fisher and Gary S. Stetz, II to its Board of Directors, effective July 1, 2026. The company noted that Gary S. Stetz, II is the son of Gary Stetz, the Interim Chief Executive Officer, but otherwise there are no other arrangements or family relationships.
Key Highlights
- Hepion Pharmaceuticals appointed Danina Fisher as a director.
- Hepion Pharmaceuticals appointed Gary S. Stetz, II as a director.
- Appointments were effective immediately on July 1, 2026.
- Gary S. Stetz, II is the son of Gary Stetz, the Interim CEO.
Price Impact
More from HEPA